Dow Down 1.29% Nasdaq Down 3.25%

Oncothyreon Inc (ONTY)

-NasdaqGS
1.15 Down 0.04(3.36%) Feb 5, 4:00PM EST
Prev Close:1.19
Open:1.18
Bid:1.00 x 1600
Ask:2.50 x 200
1y Target Est:4.25
Beta:2.05012
Earnings Date:Mar 8 - Mar 14 (Est.)
Day's Range:1.13 - 1.19
52wk Range:1.13 - 4.69
Volume:789,029
Avg Vol (3m):1,283,090
Market Cap:109.17M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ONTY

Comparison

Symbol% ChgMkt Cap
ONTYDown 3.36%109.17M
GSKDown 0.54%98.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Dec-15) :-0.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback